OzUK was established to provide support for the inhalation drug delivery R&D sector. Our expertise in respiratory R&D, streamlined processes, staff provision and education means we can provide a one-stop-shop for this dynamic sector.
External link for OzUK
Unit 15, Lansdowne Court
Bumpers Way
Chippenham, Wiltshire SN14 6RZ, GB
DDL 2024 is almost upon us! Come & see us at Stand 213. We are booking out 2025 slots on our HFO1234ze/HFA152a Filling line. Get yours now, limited slots available!
DDL 2024 is almost upon us! Come & see us at Stand 213. We are booking out 2025 slots on our HFO1234ze/HFA152a Filling line. Get yours now, limited slots available!
Need it Yesterday? OZ-UK Delivers 24/7. In today’s fast-paced world, time is of the essence. That’s why we’re here. OZ-UK, a unique partnership between Australia and the UK, offers round-the-clock metered dose inhaler solutions. Our teams across two continents work tirelessly, passing the baton to ensure your projects move forward 24/7. We’re excited to announce our new HFO1234ze and HFA152a low GWP pilot line, now taking bookings for 2025 slots for your pre-feasibility studies and working with our Partners for GMP and full market production. Let us help you accelerate your pipeline. Come and book your slot at the DDL Exhibition Stand 213 and see us at the Scientific Poster session. #OZUK #GlobalCollaboration #247Support #RapidDelivery #HFO1234ze #HFA152a #LowGWP
Need it Yesterday? OZ-UK Delivers 24/7. In today’s fast-paced world, time is of the essence. That’s why we’re here. OZ-UK, short for Australia and the UK, is a unique partnership that offers round-the-clock metered dose inhaler solutions. We understand the urgency of your business needs. Our teams across two continents work tirelessly, passing the baton to ensure your projects move forward 24/7. Ready to experience the OZ-UK difference? Let’s connect and discuss your next project. #OZUK #GlobalCollaboration #247Support #RapidDelivery
Building a Brighter Future Together. OzUK's commitment to innovation within inhaled drug delivery sets the stage for innovative solutions. Licensed to possess and produce controlled drugs, we're your trusted partner for cutting-edge MDI solutions. Secure your future with OZUK. Solution and suspension MDI Experts. #InhaledDrugDelivery #lowGWP #DrugDeliveryToTheLungs
Exciting developments at Oz-UK! Our new ATEX-Rated MDI pilot plant is now operational, paving the way for innovative, sustainable MDI solutions. 🌿 Let's work together to build a healthier future. #inhaleddrugdelivery #medicaldevice #drugdevelopment #innovation #sustainability #lowgwp #mdi #respiratoryhealth https://lnkd.in/eG2VqwYd
Oz-UK is committed to a greener future. Our new pilot plant enables the development of sustainable MDI products for better respiratory health. Learn more about our commitment to sustainability. Discover how we are shaping the future of respiratory healthcare. Connect with us to discuss your next project. #inhaleddrugdelivery #medicaldevice #drugdevelopment #innovation #sustainability #lowgwp #mdi #respiratoryhealth
OzUK Unveils New ATEX-Rated Pilot Plant for Low GWP Product Development At OzUK, we are proud to announce the installation and qualification of our state-of-the-art pilot plant, designed to support the development of metered dose inhalers (MDIs) using low GWP propellants. This cutting-edge facility, fully compliant with ATEX directives, enables OzUK to produce both solution and suspension batches using 152a for pilot and feasibility studies under Good Laboratory Practice (GLP). Read more by following the link https://lnkd.in/eG2VqwYd
OzUK reposted this
On the second day of our Parma conference, we explored sustainability of inhalation products and the shift to low global warming potential propellants. Paul Young illustrated differences in atomisation between current and new green propellants. Simon Gardner and Angelo Matturro shared strategies for pMDIs with HFA152a. David Lechuga-Ballesteros covered engineered particle suspensions based on HFO1234 while Chris Baron provided insights on navigating the transition and Sergio Monti analyzed market scenarios for pMDIs. Exciting advancements to make inhalation technologies more green and more sustainable! #Sustainability #InhalationInnovation #GreenPropellants #HealthcareInnovation #DrugDelivery #InhalationTherapy #ParmaConference
It was a pleasure for the team to be invited to talk about MDI development and the transition to next-gen propellants at "Exploring the Future of Inhalation Drug Delivery' in Parma, Italy. Prof Paul Young talks about Breathing Green! Learn about OzUKs MDI development services, including rapid formulation feasibility, product development and full pilot manufacture of both suspension and solution MDIs with next-gen propellants at www.oz-uk-labs.com